The reasons for the cancer survivors who were less likely to enroll for clinical trials was the fear of increased COVID-19 exposure or having difficulties in accessing health care during the pandemic.
The reasons for the cancer survivors who were less likely to enroll for clinical trials was the fear of increased COVID-19 exposure or having difficulties in accessing health care during the pandemic.